CR vs IESC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CR demonstrates stable financial health with a Piotroski F-Score of 6/9 and exceptional liquidity, evidenced by a Current Ratio of 5.53. However, the stock is trading at a severe premium, with the current price of $180.08 vastly exceeding both the Graham Number ($67.44) and the growth-based Intrinsic Value ($41.25). While the company maintains a stellar track record of earnings beats over 25 quarters, the technical trend is currently bearish (0/100) and YoY earnings growth is nearly stagnant at 0.20%. The disconnect between fundamental value and market price suggests a high-quality business that is currently overvalued.
IESC exhibits strong fundamental health with a Piotroski F-Score of 7/9 and an exceptionally low Debt/Equity ratio of 0.07. While the company demonstrates elite profitability (ROE 41.74%) and robust earnings growth (65.8% YoY), the stock is currently trading at a premium, exceeding both its Intrinsic Value ($496.78) and the analyst target price ($458.00). The divergence between stellar operational performance and bearish insider sentiment/technical trends suggests the stock may be overextended after its massive 1-year run (+194.9%).
Compare Another Pair
CR vs IESC: Head-to-Head Comparison
This page compares Crane Company (CR) and IES Holdings, Inc. (IESC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.